---
annotations:
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Egonw
description: The 22 members of the fibroblast growth factor (FGF) family of growth
  factors mediate their cellular responses by binding to and activating the different
  isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
  FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
  processes in which cell fate and differentiation to various tissue lineages are
  determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
  sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
  that lead to the variety of cellular responses induced by this large family of growth
  factors. An alternative, FGF-independent, source of FGFR activation originates from
  the interaction with cell adhesion molecules, typically in the context of interactions
  on neural cell membranes and is crucial for neuronal survival and development.<br><br>Upon
  ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is
  activated causing phosphorylation of multiple tyrosine residues on the receptors.
  These then serve as docking sites for the recruitment of SH2 (src homology-2) or
  PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling
  enzymes. Signaling complexes are assembled and recruited to the active receptors
  resulting in a cascade of phosphorylation events.<br><br>This leads to stimulation
  of intracellular signaling pathways that control cell proliferation, cell differentiation,
  cell migration, cell survival and cell shape, depending on the cell type or stage
  of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654736
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3335
- /instance/WP3335
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3335.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The 22 members of the fibroblast growth factor (FGF) family of growth
    factors mediate their cellular responses by binding to and activating the different
    isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
    FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
    processes in which cell fate and differentiation to various tissue lineages are
    determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
    sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
    that lead to the variety of cellular responses induced by this large family of
    growth factors. An alternative, FGF-independent, source of FGFR activation originates
    from the interaction with cell adhesion molecules, typically in the context of
    interactions on neural cell membranes and is crucial for neuronal survival and
    development.<br><br>Upon ligand binding, receptor dimers are formed and their
    intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine
    residues on the receptors. These then serve as docking sites for the recruitment
    of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors,
    docking proteins or signaling enzymes. Signaling complexes are assembled and recruited
    to the active receptors resulting in a cascade of phosphorylation events.<br><br>This
    leads to stimulation of intracellular signaling pathways that control cell proliferation,
    cell differentiation, cell migration, cell survival and cell shape, depending
    on the cell type or stage of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654736
    Reactome].
  keywords:
  - Activated
  - 'PIK3CA '
  - mutant:GRB2:GAB2
  - 'MYO18A-p-2Y-FGFR1 fusion '
  - 'STAT1 '
  - 'UBB(77-152) '
  - 'BCR-FGFR1 fusion '
  - SPRY2:B-RAF
  - 'p-8Y-FGFR1c P252T '
  - FGFR1 fusion mutant
  - 'FGFR1c P252T '
  - p21 RAS:GTP
  - p-Y705-STAT3
  - Pi
  - FGFR1 mutants with
  - Activated FGFR1b
  - 'UBC(305-380) '
  - 'p-S112,S115-SPRY2 '
  - overexpressed FGFR1
  - 'PIK3R1 '
  - 'FGF20 '
  - FGFR1c
  - PP2A(A:C):SPRY2
  - 'p-6Y FGFR1(22-763):TACC1(571-805) fusion '
  - 'UBA52(1-76) '
  - FGFs
  - Ub-Activated FGFR1
  - dimers:PIK3R1
  - KAL1
  - 'FLRT3 '
  - 'p-8Y- FGFR1 R576W '
  - FGFR1c P252X mutant
  - PPA2A(A:C):SPRY2
  - mutant dimers with
  - 'KAL1 '
  - FGFR1c P252X mutants
  - 'CPSF6-p-2Y-FGFR1 fusion '
  - FGFR1c homodimer
  - Activated FGFR1c
  - 'p-T202,Y204-MAPK3 '
  - p-SPRY2:B-RAF
  - GDP
  - 'UBB(153-228) '
  - dimers bound to
  - 'S-Farn-Me PalmS NRAS '
  - 'PLCG1 '
  - 'FGFR1c '
  - 'ERLIN2(1-185):FGFR1(c.-88-822) fusion '
  - PP2A (A:C)
  - FGFRL1-binding
  - BCR-p-FGFR1 fusion
  - p-4Y-PLCG1
  - 'p-8Y-FGFR1 N546K '
  - Activated FGFR1:FRS3
  - 'PPP2CA '
  - 'FGF17-1 '
  - p-FGFR1 fusion
  - fusions:PLCG1
  - 'p-Y371-CBL '
  - 'RPS27A(1-76) '
  - 'p-5Y-FRS3 '
  - fusions:PI3K
  - 'UBB(1-76) '
  - 'UBC(457-532) '
  - 'BAG4(1-126):p-8Y FGFR1(208-822) fusion '
  - 'CNTRL-p-2Y-FGFR1 fusion '
  - DAG and IP3
  - 'FGFR1OP-FGFR1 fusion '
  - 'LRRFIP1-p-2Y-FGFR1 fusion '
  - 'FGFR1b '
  - 'p-6Y-FRS2 '
  - p-Y371-CBL:GRB2
  - 'UBC(1-76) '
  - FGF23:Klotho
  - GRB2-1
  - fusion mutant
  - Y55/Y227-pSPRY2:CBL
  - 'p-Y694-STAT5A '
  - p-SPRY2
  - SRC-1
  - 'TRIM24-p-2Y-FGFR1 fusion '
  - 'CPSF6-FGFR1 fusion '
  - plasma membrane
  - p-S111,S120-SPRY2
  - fusion:p-PLCG1
  - FGFR1:PLCG1
  - ATP
  - FGFR1:p-FRS
  - cytosolic p-FGFR1
  - Klotho bound to
  - BRAF
  - FRS3
  - activated
  - Overexpressed FGFR1
  - 'FLRT2 '
  - FGFR1 fusions
  - 'GAB1 '
  - mutant dimer
  - 'KL-1 '
  - inhibitors of
  - 'FRS2 '
  - dimers
  - 'p-8Y-FGFR1c '
  - FGFR1b homodimer
  - 'p-S112,S121-SPRY2 '
  - activity
  - FGFR1:p-FRS2:GRB2:GAB1:PI3K
  - SPRED1/2 dimer
  - FGFR1:p-8T-FRS2
  - inhibitors of FGFR1
  - cytosolic FGFR1
  - 'p-Y701-STAT1 '
  - 'BRAF '
  - p-T,Y MAPK dimers
  - FGFRL1-binding FGFs
  - 'FGFR1OP2-FGFR1 fusion '
  - GRB2:GAB1:PIK3R1
  - FGFR1:p-FRS2
  - 'MYO18A-FGFR1 fusion '
  - 'cytosolic activated FGFR1 fusion mutants '
  - Activated FGFR1:FLRT
  - dimer
  - PP2A(A:C):Y55/Y227-pSPRY2
  - PTPN11
  - P252X mutants
  - homodimers
  - 'p-Y546,Y584-PTPN11 '
  - 'UBC(381-456) '
  - homodimer
  - 'FGFR1 R576W '
  - Plasma membrane
  - 'FGF1 '
  - FGFR1:p-FRS2:p-PTPN11:p-CBL:GRB2
  - FGFR1:TKIs
  - kinase activity
  - 'p-8Y-FGFR1c P252S '
  - 'SPRY2 '
  - 'FGF9 '
  - 'FGF8-1 '
  - 'FGFR1c P252R '
  - 'p-S111,S120-SPRY2 '
  - 'pY177-BCR-p-FGFR1 fusion '
  - Activated FGFR1:SHC1
  - mutant:GRB2:p-GAB1:PI3K
  - PIK3CA
  - 'S-Farn-Me-PalmS KRAS4A '
  - FGFRL1 dimer
  - 'FLRT1 '
  - Klotho and FGFR1c
  - 'FGF23(25-251) '
  - 'FGFRL1 '
  - FGFR1:p-FRS2:p-PTPN11:GRB2:GAB1:PI3K
  - 'SPRED1 '
  - pY177-BCR1-p-FGFR1
  - 'p-Y194,Y195,Y272-SHC1-3 '
  - FGFR1:p-4Y-PLCG1
  - GTP
  - 'UBC(609-684) '
  - FGF23 bound to
  - PIK3R1
  - 'UBC(229-304) '
  - ADP
  - Activated FGFR1
  - 'ERLIN2(1-185):p-8Y FGFR1(c.-88-822) fusion '
  - Ub:Y55/Y227-pSPRY2:CBL
  - cascade
  - 'GalNAc-T178-FGF23(25-251) '
  - 'GDP '
  - 'TRIM24-FGFR1 fusion '
  - PLCG1
  - FGFR1 fusion dimers
  - FGFR1:p-FRS2:p-PTPN11
  - PI(4,5)P2
  - STAT1, STAT3
  - 'SOS1 '
  - RAF/MAP kinase
  - FGFR1:p-FRS:PTPN11
  - 'p-8Y-FGFR1c P252R '
  - 'KL-2 '
  - with enhanced
  - 'ZMYM2-FGFR1 fusion '
  - p-Y177-BCR-pY-FGFR1
  - Ub
  - mutant
  - 'S-Farn-Me KRAS4B '
  - dimer:SPRED1/2
  - FGFR1:p-FRS2:GRB2:SOS1
  - 'UBC(153-228) '
  - p-T250,T255,T385,S437-MKNK1
  - mutants and fusions
  - FGFRL1
  - FGFR1:p-SHC1:GRB2:SOS1
  - 'p-8T-FRS2 '
  - mutants and
  - PPA2A (A:C):Y55/Y227
  - 'FGF4 '
  - 'GAB2 '
  - 'p-Y55,Y227-SPRY2 '
  - 'FGF18 '
  - 'SPRED2 '
  - SHC1-2,SHC1-3
  - FGFR1:p-FRS3
  - FGFR1c-binding FGFs
  - 'p-Y-GAB2 '
  - fusion mutants
  - 'FGF22 '
  - overexpressed
  - 'PPP2CB '
  - 'Activated FGFR1 mutants '
  - FGFR1:p-SHC1
  - GRB2-1:SOS1
  - GRB2:GAB2
  - 'STAT5B '
  - 'STAT3 '
  - 'ZMYM2-p-2Y-FGFR1 fusion '
  - Activated FGFR1:FRS2
  - FGFR1b
  - 'FGFR1c P252S '
  - HS
  - KAL1:HS
  - FGFR1:p-FRS:p-PTPN11
  - 'p-8Y-FGFR1b '
  - 'p-4Y-PLCG1 '
  - 'FGFR1OP2-p-2Y-FGFR1 fusion '
  - 'HS '
  - 'FGF10 '
  - 'CNTRL-FGFR1 fusion '
  - Ub-(Y55/Y227)p-SPRY2
  - 'p-Y699-STAT5B '
  - 'SHC1-3 '
  - 'STAT5A '
  - 'FGFR1 K656E '
  - 'PPP2R1A '
  - PP2A(A:C):S112/S121-pSPRY2
  - 'CUX1-p-2Y-FGFR1 fusion '
  - 'PI(3,4,5)P3 '
  - 'p-Y705-STAT3 '
  - p-STAT5A, p-STAT5B
  - 'dovitinib '
  - p-Y701-STAT1,
  - GRB2:GAB1
  - 'CBL '
  - FGF23
  - 'LRRFIP1-FGFR1 fusion '
  - Overexpressed
  - FGFR:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1
  - FLRT1,2,3
  - 'FGFR1 N546K '
  - 'GTP '
  - S111/S120
  - FGFR1:p-FRS2:GRB2:GAB1:PIK3R1
  - Tyrosine kinase
  - bound to
  - FRS2
  - mutant:GRB2:p-GAB2:PIK3R1
  - signaling
  - CBL
  - 'FGF3 '
  - bound to FGF
  - 'FGF2(10-155) '
  - 'S-Farn-Me-2xPalmS HRAS '
  - 'CUX1-FGFR1 fusion '
  - 'SHC1-2 '
  - PPA2A
  - FGFR1b-binding FGFs
  - FGFR1c:KAL1
  - p-FGFR1 mutant
  - FGFR1 mutant dimers
  - mutant:GRB2:p-GAB2
  - STAT5A,STAT5B
  - p-SPRY2:GRB2
  - enhanced kinase
  - 'GRB2-1 '
  - 'FGF6 '
  - 'FGFR1OP-p-FGFR1 fusion '
  - (A:C):S112/S115
  - FGFs:FGFRL1 dimer
  - dimers:TKIs
  - 'BAG4(1-126):FGFR1(208-822) fusion '
  - 'p-T185,Y187-MAPK1 '
  - PI(3,4,5)P3
  - 'p-8Y-FGFR1 K656E '
  - complex:Ub-p-FRS2
  - pY177-BCR-p-FGFR1
  - 'FRS3 '
  - 'p-Y239,Y240,Y317-SHC1-2 '
  - 'FGFR1(22-763):TACC1(571-805) fusion '
  - Plasma membrane p-Y
  - FGFR1OP-p-FGFR1
  - 'BCR-p-FGFR1 fusion '
  - 'UBC(77-152) '
  - PIP3 activates AKT
  - pY177-BCR-pY-FGFR1
  - 'FGF5-1 '
  - p21 RAS:GDP
  - 'UBC(533-608) '
  - fusion mutant dimer
  - 'PTPN11 '
  license: CC0
  name: Signaling by FGFR1
seo: CreativeWork
title: Signaling by FGFR1
wpid: WP3335
---